热门资讯> 正文

Adagio Medical宣布发布美国早期可行性研究的结果，评估超低温心脏消融治疗疤痕相关室性心动过速

2026-02-04 21:10

Adagio Medical Holdings, Inc(ADGM) 0

Results demonstrated a favorable safety profile, with no device- or procedure-related major adverse events measured at both seven and 30 days, and strong acute and chronic performance. Among 14 patients with inducible VT tested both before and after ablation, 92.9% achieved non-inducibility of targeted clinical VT. At a mean follow-up of 24 weeks, antiarrhythmic drugs were either completely discontinued or reduced in 72% of the patients, and 83.3% of the patients were free from implantable cardioverter-defibrillator (ICD) shock, with a notable reduction in the overall VT burden.
Adagio's proprietary ULTC technology utilizes near-critical nitrogen to achieve temperatures approaching –196°C, enabling the creation of deeper and potentially transmural lesions compared with other existing ablation modalities. This study represents the first published U.S. clinical experience for ULTC under the FDA's EFS framework.
"The publication of this study marks an important milestone for Adagio Medical and for patients with complex ventricular arrhythmias," said Todd Usen, Chief Executive Officer of Adagio Medical. "These results highlight the potential of ultralow temperature ablation to address a significant unmet need in VT treatment and underscores the value of the FDA's Early Feasibility Study program in accelerating patient access to innovative technologies. We look forward to sharing the results of our FULCRUM-VT pivotal trial at the Heart Rhythm Society scientific meeting in April.
Patients enrolled in the EFS will be included in the safety analyses of Adagio Medical's FULCRUM-VT pivotal Investigational Device Exemption (IDE) study. FULCRUM-VT, which completed enrollment in October 2025, is designed to support U.S. regulatory approval of Adagio's vCLASTM Cryoablation System, which is expected by year end 2026,

Adagio Medical宣布发布美国早期可行性研究的结果，评估超低温心脏消融治疗疤痕相关室性心动过速

推荐文章

港股周报 | 中国大模型“春节档”打响！智谱周涨超138%；巨亏超230亿！美团周内重挫超10%

一周财经日历 | 港美股迎“春节+总统日”双假期！万亿零售巨头沃尔玛将发财报

一周IPO | 赚钱效应持续火热！年内24只上市新股“0”破发；“图模融合第一股”海致科技首日飙涨逾242%

从软件到房地产，美国多板块陷入AI恐慌抛售潮

Meta计划为智能眼镜添加人脸识别技术

危机四伏，市场却似乎毫不在意

美股机会日报 | 降息预期升温！美国1月CPI年率创去年5月来新低；净利、指引双超预期！应用材料盘前涨超10%

财报前瞻 | 英伟达Q4财报放榜在即！高盛、瑞银预计将大超预期，两大关键催化将带来意外惊喜？